Cost-effectiveness with PCSK9 inhibitors: a matter of costs

European Heart Journal - Cardiovascular Pharmacotherapy

5 January 2018

Organised by:

Author

Vorarlberg Institute for Vascular Investigation and Treatment Feldkirch , Austria